-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In recent days, the epidemic situation in India has gradually worsened out of control, drawing global attention
.
According to the data released by the Ministry of Health of India on April 25, India had 349,000 new confirmed cases and 2767 new deaths in a single day, with a total of 190,000 deaths
Screenshot of Zhang Wenhong's Weibo
Known as the "World Pharmacy", India is one of the world's major suppliers of raw materials and one of the world's major generic drug production centers.
More than 60% of India's generic drugs are exported to developed countries such as the United States, Europe and Japan, among which the US market is 40%.
% Of generic drugs come from India
.
Affected by the continuing epidemic in India, many international API supply chains have been frustrated, and the shortage of APIs has intensified.
Some API concept stocks
The capital response is so enthusiastic, can Chinese APIs replace the market share of India's APIs ? In this regard, industry experts have said that India is mainly engaged in high-end generic APIs, while China is mainly engaged in bulk export of APIs, and the two cannot be completely replaced
.
Of course, India’s production capacity is much larger than China’s.
In the post-epidemic era, the world is speeding up the comprehensive vaccination of the new crown vaccine in order to achieve herd immunity as soon as possible, open the country's doors, and expand trade
.
In this environment, how should Chinese pharmaceutical companies lay out the import and export of pharmaceuticals and open up the international supply chain? In this regard, CPhI & P-MEC China and PharmaSources will re-launch the "E-Trade Season cloud business" from March to June 2021.
Scan the QR code below to register
